These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11130083)

  • 1. The Heart and Estrogen/Progestin Replacement Study (HERS) in perspective--results not very surprising.
    Naessen T
    Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1037-41. PubMed ID: 11130083
    [No Abstract]   [Full Text] [Related]  

  • 2. Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement: HERS study was no revolution.
    Ylikorkala O
    Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1029-36. PubMed ID: 11130082
    [No Abstract]   [Full Text] [Related]  

  • 3. The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.
    Hendrix SL
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S3-5. PubMed ID: 12625631
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
    Kaunitz AM;
    Medscape Womens Health; 2002; 7(4):8. PubMed ID: 12466740
    [No Abstract]   [Full Text] [Related]  

  • 5. Be careful of what you wish for: putting the WHI Estrogen/Progestin and HERS II Trials in perspective.
    Randolph JF;
    Medscape Womens Health; 2002; 7(4):7. PubMed ID: 12466739
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD
    Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract]   [Full Text] [Related]  

  • 7. Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():411-2. PubMed ID: 12449905
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinician's review of the WHI-related literature.
    Speroff L
    Int J Fertil Womens Med; 2004; 49(6):252-67. PubMed ID: 15751264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity?
    Hermsmeyer RK; Thompson TL; Pohost GM; Kaski JC
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):387-95. PubMed ID: 18521110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormone replacement therapy in menopause and cardiovascular disease].
    Pedersen AT; Skouby SO; Jespersen J; Ottesen BS
    Ugeskr Laeger; 2002 Aug; 164(34):3973-4. PubMed ID: 12212481
    [No Abstract]   [Full Text] [Related]  

  • 11. Estrogen plus progestin may increase incidence of dementia.
    Culhane NS
    J Fam Pract; 2003 Oct; 52(10):754-5. PubMed ID: 14529594
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormone replacement therapy in menopause and cardiovascular disease--one more time].
    Os I; Tonstad S
    Tidsskr Nor Laegeforen; 2002 Aug; 122(18):1808-10. PubMed ID: 12362695
    [No Abstract]   [Full Text] [Related]  

  • 13. Focus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.
    Walsh BW
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S6-8. PubMed ID: 12625632
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?].
    Henriksson P
    Lakartidningen; 2002 Nov; 99(47):4716-9. PubMed ID: 12523045
    [No Abstract]   [Full Text] [Related]  

  • 15. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
    Stjernquist M;
    Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Positive effects of estrogens on cardiovascular health].
    Fried G
    Lakartidningen; 2002 May; 99(18):2066-7. PubMed ID: 12082786
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination hormone replacement therapy and dementia.
    Wooltorton E
    CMAJ; 2003 Jul; 169(2):133. PubMed ID: 12874164
    [No Abstract]   [Full Text] [Related]  

  • 20. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA].
    von Schoultz B
    Lakartidningen; 2002 Aug; 99(34):3276-8. PubMed ID: 12362844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.